Medical Care
Global CRISPR and CRISPR-Associated (Cas) Genes Market Research Report 2025
- May 16, 25
- ID: 246272
- Pages: 83
- Figures: 85
- Views: 11
The global market for CRISPR and CRISPR-Associated (Cas) Genes was valued at US$ 2399 million in the year 2024 and is projected to reach a revised size of US$ 16260 million by 2031, growing at a CAGR of 31.9% during the forecast period.
This report studies the CRISPR And CRISPR-Associated (Cas) Genes market.
Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of "spacer DNA" from previous exposures to a bacteriophage virus or plasmid.
The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages, and provides a form of acquired immunity. CRISPR associated proteins (Cas) use the CRISPR spacers to recognize and cut these exogenous genetic elements in a manner analogous to RNA interference in eukaryotic organisms. CRISPRs are found in approximately 40% of sequenced bacterial genomes and 90% of sequenced archaea.
Cas9 was the first nuclease discovered, followed by Cpf1, which was discovered in the CRISPR/Cpf1 system of Francisella novicida. Other such systems are thought to exist. CRISPR/Editas Medicinec2 from the bacterium Leptotrichia shahii is RNA-guided CRISPR system that targets RNA rather than DNA, and can either cleave single-stranded RNA targets or knock them down.
By delivering the Cas9 nuclease complexed with a synthetic guide RNA (gRNA) into a cell, the cell"s genome can be cut at a desired location, allowing existing genes to be removed and/or new ones added. The Cas9-gRNA complex corresponds with the CAS III crRNA complex in the above diagram. CRISPR/Cas genome editing techniques have many potential applications, including altering the germline of humans, animals, and food crops. The use of CRISPR Cas9-gRNA complex for genome editing was the AAAS"s choice for breakthrough of the year in 2015. Bioethical concerns have been expressed about the prospect of using this nascent biotechnology for editing the human germline.
Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics and Intellia therapeutics, Inc. are the top 5 players of CRISPR and CRISPR-Associated (Cas) Genes, with about 63% market shares.
CRISPR And CRISPR-Associated (Cas) Genes industry is relatively concentrated, manufacturers are mostly in the Europe and North America. Among them, North America region accounted for more than 45% of the total market of global CRISPR And CRISPR-Associated (Cas) Genes.
This report aims to provide a comprehensive presentation of the global market for CRISPR and CRISPR-Associated (Cas) Genes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPR and CRISPR-Associated (Cas) Genes.
The CRISPR and CRISPR-Associated (Cas) Genes market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CRISPR and CRISPR-Associated (Cas) Genes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CRISPR and CRISPR-Associated (Cas) Genes companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Editas Medicine
Caribou Biosciences
CRISPR therapeutics
Intellia therapeutics, Inc.
Cellectis
Horizon Discovery Plc
Sigma Aldrich
Precision Biosciences
Genscript
Sangamo Biosciences Inc.
Lonza Group Limited
Integrated DNA Technologies
New England Biolabs
Origene Technologies
Segment by Type
Genome Editing
Genetic engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
Segment by Application
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CRISPR and CRISPR-Associated (Cas) Genes company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
This report studies the CRISPR And CRISPR-Associated (Cas) Genes market.
Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of "spacer DNA" from previous exposures to a bacteriophage virus or plasmid.
The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages, and provides a form of acquired immunity. CRISPR associated proteins (Cas) use the CRISPR spacers to recognize and cut these exogenous genetic elements in a manner analogous to RNA interference in eukaryotic organisms. CRISPRs are found in approximately 40% of sequenced bacterial genomes and 90% of sequenced archaea.
Cas9 was the first nuclease discovered, followed by Cpf1, which was discovered in the CRISPR/Cpf1 system of Francisella novicida. Other such systems are thought to exist. CRISPR/Editas Medicinec2 from the bacterium Leptotrichia shahii is RNA-guided CRISPR system that targets RNA rather than DNA, and can either cleave single-stranded RNA targets or knock them down.
By delivering the Cas9 nuclease complexed with a synthetic guide RNA (gRNA) into a cell, the cell"s genome can be cut at a desired location, allowing existing genes to be removed and/or new ones added. The Cas9-gRNA complex corresponds with the CAS III crRNA complex in the above diagram. CRISPR/Cas genome editing techniques have many potential applications, including altering the germline of humans, animals, and food crops. The use of CRISPR Cas9-gRNA complex for genome editing was the AAAS"s choice for breakthrough of the year in 2015. Bioethical concerns have been expressed about the prospect of using this nascent biotechnology for editing the human germline.
Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics and Intellia therapeutics, Inc. are the top 5 players of CRISPR and CRISPR-Associated (Cas) Genes, with about 63% market shares.
CRISPR And CRISPR-Associated (Cas) Genes industry is relatively concentrated, manufacturers are mostly in the Europe and North America. Among them, North America region accounted for more than 45% of the total market of global CRISPR And CRISPR-Associated (Cas) Genes.
This report aims to provide a comprehensive presentation of the global market for CRISPR and CRISPR-Associated (Cas) Genes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPR and CRISPR-Associated (Cas) Genes.
The CRISPR and CRISPR-Associated (Cas) Genes market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CRISPR and CRISPR-Associated (Cas) Genes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CRISPR and CRISPR-Associated (Cas) Genes companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Editas Medicine
Caribou Biosciences
CRISPR therapeutics
Intellia therapeutics, Inc.
Cellectis
Horizon Discovery Plc
Sigma Aldrich
Precision Biosciences
Genscript
Sangamo Biosciences Inc.
Lonza Group Limited
Integrated DNA Technologies
New England Biolabs
Origene Technologies
Segment by Type
Genome Editing
Genetic engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
Segment by Application
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CRISPR and CRISPR-Associated (Cas) Genes company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Genome Editing
1.2.3 Genetic engineering
1.2.4 gRNA Database/Gene Librar
1.2.5 CRISPR Plasmid
1.2.6 Human Stem Cells
1.2.7 Genetically Modified Organisms/Crops
1.2.8 Cell Line Engineering
1.3 Market by Application
1.3.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biotechnology Companies
1.3.3 Pharmaceutical Companies
1.3.4 Academic Institutes
1.3.5 Research and Development Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Perspective (2020-2031)
2.2 Global CRISPR and CRISPR-Associated (Cas) Genes Growth Trends by Region
2.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 CRISPR and CRISPR-Associated (Cas) Genes Historic Market Size by Region (2020-2025)
2.2.3 CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Region (2026-2031)
2.3 CRISPR and CRISPR-Associated (Cas) Genes Market Dynamics
2.3.1 CRISPR and CRISPR-Associated (Cas) Genes Industry Trends
2.3.2 CRISPR and CRISPR-Associated (Cas) Genes Market Drivers
2.3.3 CRISPR and CRISPR-Associated (Cas) Genes Market Challenges
2.3.4 CRISPR and CRISPR-Associated (Cas) Genes Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Revenue
3.1.1 Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Revenue (2020-2025)
3.1.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Players (2020-2025)
3.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CRISPR and CRISPR-Associated (Cas) Genes Revenue
3.4 Global CRISPR and CRISPR-Associated (Cas) Genes Market Concentration Ratio
3.4.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRISPR and CRISPR-Associated (Cas) Genes Revenue in 2024
3.5 Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes Head office and Area Served
3.6 Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes, Product and Application
3.7 Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CRISPR and CRISPR-Associated (Cas) Genes Breakdown Data by Type
4.1 Global CRISPR and CRISPR-Associated (Cas) Genes Historic Market Size by Type (2020-2025)
4.2 Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Type (2026-2031)
5 CRISPR and CRISPR-Associated (Cas) Genes Breakdown Data by Application
5.1 Global CRISPR and CRISPR-Associated (Cas) Genes Historic Market Size by Application (2020-2025)
5.2 Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size (2020-2031)
6.2 North America CRISPR and CRISPR-Associated (Cas) Genes Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2020-2025)
6.4 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size (2020-2031)
7.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2020-2025)
7.4 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size (2020-2031)
8.2 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2020-2025)
8.4 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size (2020-2031)
9.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2020-2025)
9.4 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size (2020-2031)
10.2 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2020-2025)
10.4 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.1.4 Thermo Fisher Scientific Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Editas Medicine
11.2.1 Editas Medicine Company Details
11.2.2 Editas Medicine Business Overview
11.2.3 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.2.4 Editas Medicine Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
11.2.5 Editas Medicine Recent Development
11.3 Caribou Biosciences
11.3.1 Caribou Biosciences Company Details
11.3.2 Caribou Biosciences Business Overview
11.3.3 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.3.4 Caribou Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
11.3.5 Caribou Biosciences Recent Development
11.4 CRISPR therapeutics
11.4.1 CRISPR therapeutics Company Details
11.4.2 CRISPR therapeutics Business Overview
11.4.3 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.4.4 CRISPR therapeutics Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
11.4.5 CRISPR therapeutics Recent Development
11.5 Intellia therapeutics, Inc.
11.5.1 Intellia therapeutics, Inc. Company Details
11.5.2 Intellia therapeutics, Inc. Business Overview
11.5.3 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.5.4 Intellia therapeutics, Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
11.5.5 Intellia therapeutics, Inc. Recent Development
11.6 Cellectis
11.6.1 Cellectis Company Details
11.6.2 Cellectis Business Overview
11.6.3 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.6.4 Cellectis Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
11.6.5 Cellectis Recent Development
11.7 Horizon Discovery Plc
11.7.1 Horizon Discovery Plc Company Details
11.7.2 Horizon Discovery Plc Business Overview
11.7.3 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.7.4 Horizon Discovery Plc Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
11.7.5 Horizon Discovery Plc Recent Development
11.8 Sigma Aldrich
11.8.1 Sigma Aldrich Company Details
11.8.2 Sigma Aldrich Business Overview
11.8.3 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.8.4 Sigma Aldrich Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
11.8.5 Sigma Aldrich Recent Development
11.9 Precision Biosciences
11.9.1 Precision Biosciences Company Details
11.9.2 Precision Biosciences Business Overview
11.9.3 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.9.4 Precision Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
11.9.5 Precision Biosciences Recent Development
11.10 Genscript
11.10.1 Genscript Company Details
11.10.2 Genscript Business Overview
11.10.3 Genscript CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.10.4 Genscript Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
11.10.5 Genscript Recent Development
11.11 Sangamo Biosciences Inc.
11.11.1 Sangamo Biosciences Inc. Company Details
11.11.2 Sangamo Biosciences Inc. Business Overview
11.11.3 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.11.4 Sangamo Biosciences Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
11.11.5 Sangamo Biosciences Inc. Recent Development
11.12 Lonza Group Limited
11.12.1 Lonza Group Limited Company Details
11.12.2 Lonza Group Limited Business Overview
11.12.3 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.12.4 Lonza Group Limited Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
11.12.5 Lonza Group Limited Recent Development
11.13 Integrated DNA Technologies
11.13.1 Integrated DNA Technologies Company Details
11.13.2 Integrated DNA Technologies Business Overview
11.13.3 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.13.4 Integrated DNA Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
11.13.5 Integrated DNA Technologies Recent Development
11.14 New England Biolabs
11.14.1 New England Biolabs Company Details
11.14.2 New England Biolabs Business Overview
11.14.3 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.14.4 New England Biolabs Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
11.14.5 New England Biolabs Recent Development
11.15 Origene Technologies
11.15.1 Origene Technologies Company Details
11.15.2 Origene Technologies Business Overview
11.15.3 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.15.4 Origene Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
11.15.5 Origene Technologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Genome Editing
1.2.3 Genetic engineering
1.2.4 gRNA Database/Gene Librar
1.2.5 CRISPR Plasmid
1.2.6 Human Stem Cells
1.2.7 Genetically Modified Organisms/Crops
1.2.8 Cell Line Engineering
1.3 Market by Application
1.3.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biotechnology Companies
1.3.3 Pharmaceutical Companies
1.3.4 Academic Institutes
1.3.5 Research and Development Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Perspective (2020-2031)
2.2 Global CRISPR and CRISPR-Associated (Cas) Genes Growth Trends by Region
2.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 CRISPR and CRISPR-Associated (Cas) Genes Historic Market Size by Region (2020-2025)
2.2.3 CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Region (2026-2031)
2.3 CRISPR and CRISPR-Associated (Cas) Genes Market Dynamics
2.3.1 CRISPR and CRISPR-Associated (Cas) Genes Industry Trends
2.3.2 CRISPR and CRISPR-Associated (Cas) Genes Market Drivers
2.3.3 CRISPR and CRISPR-Associated (Cas) Genes Market Challenges
2.3.4 CRISPR and CRISPR-Associated (Cas) Genes Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Revenue
3.1.1 Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Revenue (2020-2025)
3.1.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Players (2020-2025)
3.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CRISPR and CRISPR-Associated (Cas) Genes Revenue
3.4 Global CRISPR and CRISPR-Associated (Cas) Genes Market Concentration Ratio
3.4.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRISPR and CRISPR-Associated (Cas) Genes Revenue in 2024
3.5 Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes Head office and Area Served
3.6 Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes, Product and Application
3.7 Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CRISPR and CRISPR-Associated (Cas) Genes Breakdown Data by Type
4.1 Global CRISPR and CRISPR-Associated (Cas) Genes Historic Market Size by Type (2020-2025)
4.2 Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Type (2026-2031)
5 CRISPR and CRISPR-Associated (Cas) Genes Breakdown Data by Application
5.1 Global CRISPR and CRISPR-Associated (Cas) Genes Historic Market Size by Application (2020-2025)
5.2 Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size (2020-2031)
6.2 North America CRISPR and CRISPR-Associated (Cas) Genes Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2020-2025)
6.4 North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size (2020-2031)
7.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2020-2025)
7.4 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size (2020-2031)
8.2 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2020-2025)
8.4 Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size (2020-2031)
9.2 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2020-2025)
9.4 Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size (2020-2031)
10.2 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2020-2025)
10.4 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.1.4 Thermo Fisher Scientific Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Editas Medicine
11.2.1 Editas Medicine Company Details
11.2.2 Editas Medicine Business Overview
11.2.3 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.2.4 Editas Medicine Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
11.2.5 Editas Medicine Recent Development
11.3 Caribou Biosciences
11.3.1 Caribou Biosciences Company Details
11.3.2 Caribou Biosciences Business Overview
11.3.3 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.3.4 Caribou Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
11.3.5 Caribou Biosciences Recent Development
11.4 CRISPR therapeutics
11.4.1 CRISPR therapeutics Company Details
11.4.2 CRISPR therapeutics Business Overview
11.4.3 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.4.4 CRISPR therapeutics Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
11.4.5 CRISPR therapeutics Recent Development
11.5 Intellia therapeutics, Inc.
11.5.1 Intellia therapeutics, Inc. Company Details
11.5.2 Intellia therapeutics, Inc. Business Overview
11.5.3 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.5.4 Intellia therapeutics, Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
11.5.5 Intellia therapeutics, Inc. Recent Development
11.6 Cellectis
11.6.1 Cellectis Company Details
11.6.2 Cellectis Business Overview
11.6.3 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.6.4 Cellectis Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
11.6.5 Cellectis Recent Development
11.7 Horizon Discovery Plc
11.7.1 Horizon Discovery Plc Company Details
11.7.2 Horizon Discovery Plc Business Overview
11.7.3 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.7.4 Horizon Discovery Plc Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
11.7.5 Horizon Discovery Plc Recent Development
11.8 Sigma Aldrich
11.8.1 Sigma Aldrich Company Details
11.8.2 Sigma Aldrich Business Overview
11.8.3 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.8.4 Sigma Aldrich Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
11.8.5 Sigma Aldrich Recent Development
11.9 Precision Biosciences
11.9.1 Precision Biosciences Company Details
11.9.2 Precision Biosciences Business Overview
11.9.3 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.9.4 Precision Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
11.9.5 Precision Biosciences Recent Development
11.10 Genscript
11.10.1 Genscript Company Details
11.10.2 Genscript Business Overview
11.10.3 Genscript CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.10.4 Genscript Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
11.10.5 Genscript Recent Development
11.11 Sangamo Biosciences Inc.
11.11.1 Sangamo Biosciences Inc. Company Details
11.11.2 Sangamo Biosciences Inc. Business Overview
11.11.3 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.11.4 Sangamo Biosciences Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
11.11.5 Sangamo Biosciences Inc. Recent Development
11.12 Lonza Group Limited
11.12.1 Lonza Group Limited Company Details
11.12.2 Lonza Group Limited Business Overview
11.12.3 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.12.4 Lonza Group Limited Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
11.12.5 Lonza Group Limited Recent Development
11.13 Integrated DNA Technologies
11.13.1 Integrated DNA Technologies Company Details
11.13.2 Integrated DNA Technologies Business Overview
11.13.3 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.13.4 Integrated DNA Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
11.13.5 Integrated DNA Technologies Recent Development
11.14 New England Biolabs
11.14.1 New England Biolabs Company Details
11.14.2 New England Biolabs Business Overview
11.14.3 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.14.4 New England Biolabs Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
11.14.5 New England Biolabs Recent Development
11.15 Origene Technologies
11.15.1 Origene Technologies Company Details
11.15.2 Origene Technologies Business Overview
11.15.3 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Introduction
11.15.4 Origene Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
11.15.5 Origene Technologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Genome Editing
Table 3. Key Players of Genetic engineering
Table 4. Key Players of gRNA Database/Gene Librar
Table 5. Key Players of CRISPR Plasmid
Table 6. Key Players of Human Stem Cells
Table 7. Key Players of Genetically Modified Organisms/Crops
Table 8. Key Players of Cell Line Engineering
Table 9. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2020-2025) & (US$ Million)
Table 12. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Region (2020-2025)
Table 13. Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 14. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Region (2026-2031)
Table 15. CRISPR and CRISPR-Associated (Cas) Genes Market Trends
Table 16. CRISPR and CRISPR-Associated (Cas) Genes Market Drivers
Table 17. CRISPR and CRISPR-Associated (Cas) Genes Market Challenges
Table 18. CRISPR and CRISPR-Associated (Cas) Genes Market Restraints
Table 19. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Players (2020-2025) & (US$ Million)
Table 20. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Players (2020-2025)
Table 21. Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR and CRISPR-Associated (Cas) Genes as of 2024)
Table 22. Ranking of Global Top CRISPR and CRISPR-Associated (Cas) Genes Companies by Revenue (US$ Million) in 2024
Table 23. Global 5 Largest Players Market Share by CRISPR and CRISPR-Associated (Cas) Genes Revenue (CR5 and HHI) & (2020-2025)
Table 24. Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes, Headquarters and Area Served
Table 25. Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes, Product and Application
Table 26. Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2020-2025) & (US$ Million)
Table 29. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Type (2020-2025)
Table 30. Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 31. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Type (2026-2031)
Table 32. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2020-2025) & (US$ Million)
Table 33. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application (2020-2025)
Table 34. Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 35. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application (2026-2031)
Table 36. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2020-2025) & (US$ Million)
Table 38. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2026-2031) & (US$ Million)
Table 39. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2020-2025) & (US$ Million)
Table 41. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2026-2031) & (US$ Million)
Table 42. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2020-2025) & (US$ Million)
Table 44. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2026-2031) & (US$ Million)
Table 45. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2020-2025) & (US$ Million)
Table 47. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2026-2031) & (US$ Million)
Table 48. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2020-2025) & (US$ Million)
Table 50. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2026-2031) & (US$ Million)
Table 51. Thermo Fisher Scientific Company Details
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product
Table 54. Thermo Fisher Scientific Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 55. Thermo Fisher Scientific Recent Development
Table 56. Editas Medicine Company Details
Table 57. Editas Medicine Business Overview
Table 58. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product
Table 59. Editas Medicine Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 60. Editas Medicine Recent Development
Table 61. Caribou Biosciences Company Details
Table 62. Caribou Biosciences Business Overview
Table 63. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product
Table 64. Caribou Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 65. Caribou Biosciences Recent Development
Table 66. CRISPR therapeutics Company Details
Table 67. CRISPR therapeutics Business Overview
Table 68. CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product
Table 69. CRISPR therapeutics Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 70. CRISPR therapeutics Recent Development
Table 71. Intellia therapeutics, Inc. Company Details
Table 72. Intellia therapeutics, Inc. Business Overview
Table 73. Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Product
Table 74. Intellia therapeutics, Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 75. Intellia therapeutics, Inc. Recent Development
Table 76. Cellectis Company Details
Table 77. Cellectis Business Overview
Table 78. Cellectis CRISPR and CRISPR-Associated (Cas) Genes Product
Table 79. Cellectis Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 80. Cellectis Recent Development
Table 81. Horizon Discovery Plc Company Details
Table 82. Horizon Discovery Plc Business Overview
Table 83. Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Product
Table 84. Horizon Discovery Plc Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 85. Horizon Discovery Plc Recent Development
Table 86. Sigma Aldrich Company Details
Table 87. Sigma Aldrich Business Overview
Table 88. Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Product
Table 89. Sigma Aldrich Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 90. Sigma Aldrich Recent Development
Table 91. Precision Biosciences Company Details
Table 92. Precision Biosciences Business Overview
Table 93. Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product
Table 94. Precision Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 95. Precision Biosciences Recent Development
Table 96. Genscript Company Details
Table 97. Genscript Business Overview
Table 98. Genscript CRISPR and CRISPR-Associated (Cas) Genes Product
Table 99. Genscript Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 100. Genscript Recent Development
Table 101. Sangamo Biosciences Inc. Company Details
Table 102. Sangamo Biosciences Inc. Business Overview
Table 103. Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Product
Table 104. Sangamo Biosciences Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 105. Sangamo Biosciences Inc. Recent Development
Table 106. Lonza Group Limited Company Details
Table 107. Lonza Group Limited Business Overview
Table 108. Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Product
Table 109. Lonza Group Limited Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 110. Lonza Group Limited Recent Development
Table 111. Integrated DNA Technologies Company Details
Table 112. Integrated DNA Technologies Business Overview
Table 113. Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Product
Table 114. Integrated DNA Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 115. Integrated DNA Technologies Recent Development
Table 116. New England Biolabs Company Details
Table 117. New England Biolabs Business Overview
Table 118. New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Product
Table 119. New England Biolabs Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 120. New England Biolabs Recent Development
Table 121. Origene Technologies Company Details
Table 122. Origene Technologies Business Overview
Table 123. Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Product
Table 124. Origene Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 125. Origene Technologies Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
Table 129. Authors List of This Report
List of Figures
Figure 1. CRISPR and CRISPR-Associated (Cas) Genes Picture
Figure 2. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type: 2024 VS 2031
Figure 4. Genome Editing Features
Figure 5. Genetic engineering Features
Figure 6. gRNA Database/Gene Librar Features
Figure 7. CRISPR Plasmid Features
Figure 8. Human Stem Cells Features
Figure 9. Genetically Modified Organisms/Crops Features
Figure 10. Cell Line Engineering Features
Figure 11. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2020-2031) & (US$ Million)
Figure 12. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application: 2024 VS 2031
Figure 13. Biotechnology Companies Case Studies
Figure 14. Pharmaceutical Companies Case Studies
Figure 15. Academic Institutes Case Studies
Figure 16. Research and Development Institutes Case Studies
Figure 17. CRISPR and CRISPR-Associated (Cas) Genes Report Years Considered
Figure 18. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 19. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Region: 2024 VS 2031
Figure 21. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Players in 2024
Figure 22. Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR and CRISPR-Associated (Cas) Genes as of 2024)
Figure 23. The Top 10 and 5 Players Market Share by CRISPR and CRISPR-Associated (Cas) Genes Revenue in 2024
Figure 24. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. North America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Country (2020-2031)
Figure 26. United States CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Canada CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Share by Country (2020-2031)
Figure 30. Germany CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. France CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. U.K. CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Italy CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Russia CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Nordic Countries CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Share by Region (2020-2031)
Figure 38. China CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Japan CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. South Korea CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. India CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Australia CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Country (2020-2031)
Figure 46. Mexico CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Brazil CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Share by Country (2020-2031)
Figure 50. Turkey CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. UAE CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Thermo Fisher Scientific Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 54. Editas Medicine Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 55. Caribou Biosciences Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 56. CRISPR therapeutics Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 57. Intellia therapeutics, Inc. Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 58. Cellectis Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 59. Horizon Discovery Plc Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 60. Sigma Aldrich Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 61. Precision Biosciences Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 62. Genscript Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 63. Sangamo Biosciences Inc. Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 64. Lonza Group Limited Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 65. Integrated DNA Technologies Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 66. New England Biolabs Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 67. Origene Technologies Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Table 1. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Genome Editing
Table 3. Key Players of Genetic engineering
Table 4. Key Players of gRNA Database/Gene Librar
Table 5. Key Players of CRISPR Plasmid
Table 6. Key Players of Human Stem Cells
Table 7. Key Players of Genetically Modified Organisms/Crops
Table 8. Key Players of Cell Line Engineering
Table 9. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2020-2025) & (US$ Million)
Table 12. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Region (2020-2025)
Table 13. Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 14. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Region (2026-2031)
Table 15. CRISPR and CRISPR-Associated (Cas) Genes Market Trends
Table 16. CRISPR and CRISPR-Associated (Cas) Genes Market Drivers
Table 17. CRISPR and CRISPR-Associated (Cas) Genes Market Challenges
Table 18. CRISPR and CRISPR-Associated (Cas) Genes Market Restraints
Table 19. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Players (2020-2025) & (US$ Million)
Table 20. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Players (2020-2025)
Table 21. Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR and CRISPR-Associated (Cas) Genes as of 2024)
Table 22. Ranking of Global Top CRISPR and CRISPR-Associated (Cas) Genes Companies by Revenue (US$ Million) in 2024
Table 23. Global 5 Largest Players Market Share by CRISPR and CRISPR-Associated (Cas) Genes Revenue (CR5 and HHI) & (2020-2025)
Table 24. Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes, Headquarters and Area Served
Table 25. Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes, Product and Application
Table 26. Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2020-2025) & (US$ Million)
Table 29. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Type (2020-2025)
Table 30. Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 31. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Type (2026-2031)
Table 32. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2020-2025) & (US$ Million)
Table 33. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application (2020-2025)
Table 34. Global CRISPR and CRISPR-Associated (Cas) Genes Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 35. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Application (2026-2031)
Table 36. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2020-2025) & (US$ Million)
Table 38. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2026-2031) & (US$ Million)
Table 39. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2020-2025) & (US$ Million)
Table 41. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2026-2031) & (US$ Million)
Table 42. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2020-2025) & (US$ Million)
Table 44. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2026-2031) & (US$ Million)
Table 45. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2020-2025) & (US$ Million)
Table 47. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2026-2031) & (US$ Million)
Table 48. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2020-2025) & (US$ Million)
Table 50. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2026-2031) & (US$ Million)
Table 51. Thermo Fisher Scientific Company Details
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product
Table 54. Thermo Fisher Scientific Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 55. Thermo Fisher Scientific Recent Development
Table 56. Editas Medicine Company Details
Table 57. Editas Medicine Business Overview
Table 58. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product
Table 59. Editas Medicine Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 60. Editas Medicine Recent Development
Table 61. Caribou Biosciences Company Details
Table 62. Caribou Biosciences Business Overview
Table 63. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product
Table 64. Caribou Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 65. Caribou Biosciences Recent Development
Table 66. CRISPR therapeutics Company Details
Table 67. CRISPR therapeutics Business Overview
Table 68. CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product
Table 69. CRISPR therapeutics Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 70. CRISPR therapeutics Recent Development
Table 71. Intellia therapeutics, Inc. Company Details
Table 72. Intellia therapeutics, Inc. Business Overview
Table 73. Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Product
Table 74. Intellia therapeutics, Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 75. Intellia therapeutics, Inc. Recent Development
Table 76. Cellectis Company Details
Table 77. Cellectis Business Overview
Table 78. Cellectis CRISPR and CRISPR-Associated (Cas) Genes Product
Table 79. Cellectis Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 80. Cellectis Recent Development
Table 81. Horizon Discovery Plc Company Details
Table 82. Horizon Discovery Plc Business Overview
Table 83. Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Product
Table 84. Horizon Discovery Plc Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 85. Horizon Discovery Plc Recent Development
Table 86. Sigma Aldrich Company Details
Table 87. Sigma Aldrich Business Overview
Table 88. Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Product
Table 89. Sigma Aldrich Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 90. Sigma Aldrich Recent Development
Table 91. Precision Biosciences Company Details
Table 92. Precision Biosciences Business Overview
Table 93. Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product
Table 94. Precision Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 95. Precision Biosciences Recent Development
Table 96. Genscript Company Details
Table 97. Genscript Business Overview
Table 98. Genscript CRISPR and CRISPR-Associated (Cas) Genes Product
Table 99. Genscript Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 100. Genscript Recent Development
Table 101. Sangamo Biosciences Inc. Company Details
Table 102. Sangamo Biosciences Inc. Business Overview
Table 103. Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Product
Table 104. Sangamo Biosciences Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 105. Sangamo Biosciences Inc. Recent Development
Table 106. Lonza Group Limited Company Details
Table 107. Lonza Group Limited Business Overview
Table 108. Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Product
Table 109. Lonza Group Limited Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 110. Lonza Group Limited Recent Development
Table 111. Integrated DNA Technologies Company Details
Table 112. Integrated DNA Technologies Business Overview
Table 113. Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Product
Table 114. Integrated DNA Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 115. Integrated DNA Technologies Recent Development
Table 116. New England Biolabs Company Details
Table 117. New England Biolabs Business Overview
Table 118. New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Product
Table 119. New England Biolabs Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 120. New England Biolabs Recent Development
Table 121. Origene Technologies Company Details
Table 122. Origene Technologies Business Overview
Table 123. Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Product
Table 124. Origene Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025) & (US$ Million)
Table 125. Origene Technologies Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
Table 129. Authors List of This Report
List of Figures
Figure 1. CRISPR and CRISPR-Associated (Cas) Genes Picture
Figure 2. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type: 2024 VS 2031
Figure 4. Genome Editing Features
Figure 5. Genetic engineering Features
Figure 6. gRNA Database/Gene Librar Features
Figure 7. CRISPR Plasmid Features
Figure 8. Human Stem Cells Features
Figure 9. Genetically Modified Organisms/Crops Features
Figure 10. Cell Line Engineering Features
Figure 11. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2020-2031) & (US$ Million)
Figure 12. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application: 2024 VS 2031
Figure 13. Biotechnology Companies Case Studies
Figure 14. Pharmaceutical Companies Case Studies
Figure 15. Academic Institutes Case Studies
Figure 16. Research and Development Institutes Case Studies
Figure 17. CRISPR and CRISPR-Associated (Cas) Genes Report Years Considered
Figure 18. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 19. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Region: 2024 VS 2031
Figure 21. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Players in 2024
Figure 22. Global Top CRISPR and CRISPR-Associated (Cas) Genes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR and CRISPR-Associated (Cas) Genes as of 2024)
Figure 23. The Top 10 and 5 Players Market Share by CRISPR and CRISPR-Associated (Cas) Genes Revenue in 2024
Figure 24. North America CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. North America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Country (2020-2031)
Figure 26. United States CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Canada CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Share by Country (2020-2031)
Figure 30. Germany CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. France CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. U.K. CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Italy CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Russia CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Nordic Countries CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific CRISPR and CRISPR-Associated (Cas) Genes Market Share by Region (2020-2031)
Figure 38. China CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Japan CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. South Korea CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. India CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Australia CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America CRISPR and CRISPR-Associated (Cas) Genes Market Share by Country (2020-2031)
Figure 46. Mexico CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Brazil CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Share by Country (2020-2031)
Figure 50. Turkey CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. UAE CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Thermo Fisher Scientific Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 54. Editas Medicine Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 55. Caribou Biosciences Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 56. CRISPR therapeutics Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 57. Intellia therapeutics, Inc. Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 58. Cellectis Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 59. Horizon Discovery Plc Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 60. Sigma Aldrich Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 61. Precision Biosciences Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 62. Genscript Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 63. Sangamo Biosciences Inc. Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 64. Lonza Group Limited Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 65. Integrated DNA Technologies Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 66. New England Biolabs Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 67. Origene Technologies Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2020-2025)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232